Loss of Microbiota-Mediated Colonization Resistance toClostridium difficileInfection With Oral Vancomycin Compared With Metronidazole

The Evolution of Urban C. difficile Infection (CDI): CDI in 2009–2011 Is Less Severe and has Better Outcomes Than CDI in 2006–2008

(2014) Paul Feuerstadt et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Alteration of the Murine Gastrointestinal Microbiota by Tigecycline Leads to Increased Susceptibility to Clostridium difficile Infection

(2014) C. M. Bassis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk of Clostridium difficile Infection in Hospitalized Patients Receiving Metronidazole for a Non–C difficile Infection

(2014) Sandra Rodriguez et al.   Clinical Gastroenterology and Hepatology

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

(2014) Stuart Johnson et al.   CLINICAL INFECTIOUS DISEASES

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

(2014) Charlie G. Buffie et al.   NATURE

Comparative Effectiveness ofClostridium difficileTreatments

(2013) Dimitri M. Drekonja et al.   ANNALS OF INTERNAL MEDICINE

Appropriateness of empiric therapy in patients with suspectedClostridium difficileinfection

(2013) Elie Saade et al.   CURRENT MEDICAL RESEARCH AND OPINION

Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis

(2013) Claudia Slimings et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile

(2013) David W. Eyre et al.   JOURNAL OF INFECTIOUS DISEASES

Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole

(2013) Turki Abujamel et al.   PLoS One

Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice

(2012) C. A. Warren et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice

(2012) Carles Ubeda et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Emergence and global spread of epidemic healthcare-associated Clostridium difficile

(2012) Miao He et al.   NATURE GENETICS

Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis

(2011) Charlie G. Buffie et al.   INFECTION AND IMMUNITY

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans

(2010) Carles Ubeda et al.   JOURNAL OF CLINICAL INVESTIGATION

Clostridium difficile infection in Europe: a hospital-based survey

(2010) Martijn P Bauer et al.   LANCET

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities

(2009) P. D. Schloss et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Historical Perspectives on Studies ofClostridium difficileandC. difficileInfection

(2008) John G. Bartlett   CLINICAL INFECTIOUS DISEASES

A Mouse Model of Clostridium difficile–Associated Disease

(2008) Xinhua Chen et al.   GASTROENTEROLOGY

Meta-analysis to assess risk factors for recurrent Clostridium difficile infection

(2008) K.W. Garey et al.   JOURNAL OF HOSPITAL INFECTION